These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis and evaluation of 4-quinazolinone compounds as potential antimalarial agents. Zhu S; Wang J; Chandrashekar G; Smith E; Liu X; Zhang Y Eur J Med Chem; 2010 Sep; 45(9):3864-9. PubMed ID: 20538379 [TBL] [Abstract][Full Text] [Related]
6. Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy. Baragaña B; Norcross NR; Wilson C; Porzelle A; Hallyburton I; Grimaldi R; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Wyatt PG; Delves MJ; Meister S; Duffy S; Avery VM; Winzeler EA; Sinden RE; Wittlin S; Frearson JA; Gray DW; Fairlamb AH; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH J Med Chem; 2016 Nov; 59(21):9672-9685. PubMed ID: 27631715 [TBL] [Abstract][Full Text] [Related]
7. Discovery and development of 2-aminobenzimidazoles as potent antimalarials. Devine SM; Challis MP; Kigotho JK; Siddiqui G; De Paoli A; MacRaild CA; Avery VM; Creek DJ; Norton RS; Scammells PJ Eur J Med Chem; 2021 Oct; 221():113518. PubMed ID: 34058708 [TBL] [Abstract][Full Text] [Related]
8. Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate. Zhang YK; Plattner JJ; Easom EE; Jacobs RT; Guo D; Freund YR; Berry P; Ciaravino V; Erve JCL; Rosenthal PJ; Campo B; Gamo FJ; Sanz LM; Cao J J Med Chem; 2017 Jul; 60(13):5889-5908. PubMed ID: 28635296 [TBL] [Abstract][Full Text] [Related]
9. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium. Liang X; Jiang Z; Huang Z; Li F; Chen C; Hu C; Wang W; Hu Z; Liu Q; Wang B; Wang L; Qi Z; Liu J; Jiang L; Liu Q Eur J Med Chem; 2020 Feb; 188():112012. PubMed ID: 31911293 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimalarial activity of new atovaquone derivatives. El Hage S; Ane M; Stigliani JL; Marjorie M; Vial H; Baziard-Mouysset G; Payard M Eur J Med Chem; 2009 Nov; 44(11):4778-82. PubMed ID: 19747753 [TBL] [Abstract][Full Text] [Related]
11. Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies. Ongarora DS; Strydom N; Wicht K; Njoroge M; Wiesner L; Egan TJ; Wittlin S; Jurva U; Masimirembwa CM; Chibale K Bioorg Med Chem; 2015 Sep; 23(17):5419-32. PubMed ID: 26264839 [TBL] [Abstract][Full Text] [Related]
12. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR. Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829 [TBL] [Abstract][Full Text] [Related]
13. Quest for a potent antimalarial drug lead: Synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines. Mizukawa Y; Ikegami-Kawai M; Horiuchi M; Kaiser M; Kojima M; Sakanoue S; Miyagi S; Nanga Chick C; Togashi H; Tsubuki M; Ihara M; Usuki T; Itoh I Bioorg Med Chem; 2021 Mar; 33():116018. PubMed ID: 33524940 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives. Whittell LR; Batty KT; Wong RP; Bolitho EM; Fox SA; Davis TM; Murray PE Bioorg Med Chem; 2011 Dec; 19(24):7519-25. PubMed ID: 22055713 [TBL] [Abstract][Full Text] [Related]
15. Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity. Bailey BL; Nguyen W; Ngo A; Goodman CD; Gancheva MR; Favuzza P; Sanz LM; Gamo FJ; Lowes KN; McFadden GI; Wilson DW; Laleu B; Brand S; Jackson PF; Cowman AF; Sleebs BE Bioorg Chem; 2021 Oct; 115():105244. PubMed ID: 34452759 [TBL] [Abstract][Full Text] [Related]
16. In vivo antimalarial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives. Birhan YS; Bekhit AA; Hymete A BMC Res Notes; 2015 Oct; 8():589. PubMed ID: 26486987 [TBL] [Abstract][Full Text] [Related]
17. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains. Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538 [TBL] [Abstract][Full Text] [Related]
18. Designing novel inhibitors against falcipain-2 of Plasmodium falciparum. Himangini ; Pathak DP; Sharma V; Kumar S Bioorg Med Chem Lett; 2018 May; 28(9):1566-1569. PubMed ID: 29602682 [TBL] [Abstract][Full Text] [Related]
19. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion. Nguyen W; Dans MG; Ngo A; Gancheva MR; Romeo O; Duffy S; de Koning-Ward TF; Lowes KN; Sabroux HJ; Avery VM; Wilson DW; Gilson PR; Sleebs BE Eur J Med Chem; 2021 Mar; 214():113253. PubMed ID: 33610028 [TBL] [Abstract][Full Text] [Related]
20. Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies. Singh A; Kalamuddin M; Maqbool M; Mohmmed A; Malhotra P; Hoda N Bioorg Chem; 2021 Mar; 108():104514. PubMed ID: 33280833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]